A scoring index for disease activity in canine inflammatory bowel disease.
about
Comparison of microbiological, histological, and immunomodulatory parameters in response to treatment with either combination therapy with prednisone and metronidazole or probiotic VSL#3 strains in dogs with idiopathic inflammatory bowel disease16S rRNA gene pyrosequencing reveals bacterial dysbiosis in the duodenum of dogs with idiopathic inflammatory bowel diseaseImmunomodulatory drugs and their application to the management of canine immune-mediated disease.Owner assessment of pruritus and gastrointestinal signs in apparently healthy dogs with no history of cutaneous or noncutaneous disease.Effectiveness of a new dietetic weight management food to achieve weight loss in client-owned obese cats.Acute phase response in animals: a review.Identification of serum biomarkers in dogs naturally infected with Babesia canis canis using a proteomic approach.Inflammatory bowel disease in the dog: differences and similarities with humans.Chronic Diarrhea in Dogs - Retrospective Study in 136 Cases.A blinded randomised controlled trial to determine the effect of enteric coating on enzyme treatment for canine exocrine pancreatic efficiencyCanine serum C-reactive protein as a quantitative marker of the inflammatory stimulus of aseptic elective soft tissue surgery.The fecal microbiome in dogs with acute diarrhea and idiopathic inflammatory bowel diseaseCanine gut dendritic cells in the steady state and in inflammatory bowel disease.Stability of 3-bromotyrosine in serum and serum 3-bromotyrosine concentrations in dogs with gastrointestinal diseases.Use of serum C-reactive protein as an early marker of inflammatory activity in canine type II immune-mediated polyarthritis: case report.White spots on the mucosal surface of the duodenum in dogs with lymphocytic plasmacytic enteritis.Alterations of the Ileal and Colonic Mucosal Microbiota in Canine Chronic Enteropathies.Oral chondroitin sulfate and prebiotics for the treatment of canine Inflammatory Bowel Disease: a randomized, controlled clinical trial.C-reactive protein as an indicator of inflammatory responses to experimentally induced cystitis in dogs.Rifaximin is an effective alternative to metronidazole for the treatment of chronic enteropathy in dogs: a randomised trial.The characteristics of short- and long-term surviving Shiba dogs with chronic enteropathies and the risk factors for poor outcome.Serum C-reactive protein as a diagnostic biomarker in dogs with bacterial respiratory diseases.Endoscopic assessment of the duodenum in dogs with inflammatory bowel disease.Cyclooxygenase-2 and 5-lipoxygenase in dogs with chronic enteropathies.Phenotypic characterization of canine intestinal intraepithelial lymphocytes in dogs with inflammatory bowel diseaseRelationship between assays of inflammation and coagulation: a novel interpretation of the canine activated clotting timeIntestinal cytokine mRNA expression in canine inflammatory bowel disease: a meta-analysis with critical appraisal.Effects of the macrolide drug tylosin on chronic diarrhea in rhesus macaques (Macaca mulatta).The Utility of Acute-Phase Proteins in the Assessment of Treatment Response in Dogs With Bacterial Pneumonia.Illness severity scores in veterinary medicine: what can we learn?Treatment of inflammatory bowel disease (IBD) in dogs and cats.Feline idiopathic inflammatory bowel disease: what we know and what remains to be unraveled.Review of commonly used clinical pathology parameters for general gastrointestinal disease with emphasis on small animals.Biomarkers for differentiation of causes of respiratory distress in dogs and cats: Part 2--Lower airway, thromboembolic, and inflammatory diseases.Significance of clonal rearrangements of lymphocyte antigen receptor genes on the prognosis of chronic enteropathy in 22 Shiba dogs.Beyond the skeleton: the role of vitamin D in companion animal health.Concise review: Stem cell trials using companion animal disease models.HORSE SPECIES SYMPOSIUM: Canine intestinal microbiology and metagenomics: From phylogeny to function.Inflammatory bowel disease versus chronic enteropathy in dogs: are they one and the same?The importance of histologic parameters of lacteal involvement in cases of canine lymphoplasmacytic enteritis.
P2860
Q28537737-EF552621-932A-49C7-AB23-D65ACA94AD5DQ28728392-4F5F9131-B175-4128-931D-5B892521B1EBQ33393823-D3274B29-6537-4ECA-9682-E8B2E6F37445Q33465582-FEC81C5C-6C09-4786-8E02-E016B8C56DFAQ33465888-065DACCD-ADB7-4B7F-A0E0-BAAAE9FBCB61Q33560307-DAEB570B-7CB0-4177-B72B-DA857C674AB3Q33712315-96874D96-D9E7-4C06-9366-4911CDD7E5B2Q33716262-4EBE9440-830F-49F8-818D-EA799B4DC322Q33900248-AA726354-8D77-4937-91D3-916F6857EF24Q34354559-05C455EE-6B11-40AE-889C-393BE0A5DA1CQ34360727-6A24710C-BFD7-4BB0-9A42-C9BFBC09274FQ34540297-41F0388A-CD6E-4CBC-A163-10A03752AB02Q34749054-5A01C67D-514C-4D36-83ED-2F4BAD64BA50Q34987829-86F4733F-CE0E-41F9-B6AE-7C4392EBB4FBQ35005634-0F98CB43-F46D-4333-92CB-E2A81B370A24Q35013948-5124D8AE-836A-42FA-8405-B8B18F6A64D3Q35913273-23D70B2A-40D8-415B-A1AD-AD168508A5CAQ35953414-9CAF8AD3-8D9F-468E-89EA-70CB768CB907Q36066889-5134438F-5522-44FA-A65B-3E0332BDD8FAQ36157264-53DA0660-7886-48B5-A055-BD3F9FAFBE8EQ36808584-F0A4286E-68CB-4985-A209-539B32B5070AQ36975211-B0854AFE-2B0A-4EBC-A5DD-6ACFBE09249CQ36975385-C01A26D5-7321-4615-9D31-796252A1B08CQ36975533-63BE43BA-9E79-40BC-A99D-52255A442BC1Q36975560-01E9C654-9C3A-41F1-8185-D24F31C85DEAQ37152228-50CC9CEA-51D8-4BF4-9C67-343FF13F348EQ37243818-E4EC1114-A44C-491F-B53B-47B82B59CAB1Q37243876-86C084CE-F7B3-45BA-824D-7B0BAF259E88Q37601905-5D01B181-EE21-42EF-AF8F-9B0B016BE841Q37718934-12D25E85-88E4-4FDE-B577-A1CB5197B8CAQ37870151-634CCE5A-D354-4895-A6B8-87BC3BD51635Q38021980-A3EBE7BD-68A9-4B06-A3FC-F6C4C018B2C3Q38152978-21D83C42-1F0F-474B-B96C-02731DABD90CQ38514907-80F7E593-FB52-45E4-BFC9-F2E607FC0D6FQ38638233-0FCC4FC7-9C61-47E4-A1E8-8927E5CD91FAQ38783814-C770F0B1-BD20-4C79-B559-7E8A645C8918Q38804858-E42A8B99-F878-4C9D-8559-6FAAF228D809Q38861231-D59337E6-5817-4B98-A414-504A462B08F3Q38982297-6E41D726-0FD9-478B-A6FD-FB2F83E7C59DQ41589292-E32ECC72-D566-4D1B-95B8-1700B72615B5
P2860
A scoring index for disease activity in canine inflammatory bowel disease.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
A scoring index for disease activity in canine inflammatory bowel disease.
@en
A scoring index for disease activity in canine inflammatory bowel disease.
@nl
type
label
A scoring index for disease activity in canine inflammatory bowel disease.
@en
A scoring index for disease activity in canine inflammatory bowel disease.
@nl
prefLabel
A scoring index for disease activity in canine inflammatory bowel disease.
@en
A scoring index for disease activity in canine inflammatory bowel disease.
@nl
P2093
P2860
P1476
A scoring index for disease activity in canine inflammatory bowel disease.
@en
P2093
Albert E Jergens
C Alan Schreiner
Dagmar E Frank
Franklin E Ahrens
P D Eckersall
Richard Evans
Tammy J Benson
Yosiya Niyo
P2860
P304
P356
10.1111/J.1939-1676.2003.TB02450.X
P577
2003-05-01T00:00:00Z